Vaxcyte to Present at the 25th Annual Needham Virtual Healthcare Conference Apr 7, 2026 04:05PM
Vaxcyte closes $632.5 million stock offering with underwriters' option Feb 2, 2026 04:05PM
Vaxcyte Announces Closing of $632.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares Feb 2, 2026 04:05PM
Vaxcyte prices $550 million stock offering at $50 per share Jan 29, 2026 11:33PM
Vaxcyte Announces Pricing of $550 Million Public Offering Jan 29, 2026 11:33PM
View Older Stories

Feb 25, 2025 04:01PM Vaxcyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update
Apr 5, 2024 01:00PM M&A watch: 3 biotech companies that are most likely to be acquired - Needham
Apr 2, 2024 04:05PM Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
Feb 2, 2024 06:39PM Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jan 31, 2024 04:26AM Vaxcyte, Inc (PCVX) Prices 10.94M Share and Warrant Offering at $64/sh
Jan 30, 2024 11:37PM Vaxcyte Announces Pricing of $750 Million Public Offering
Jan 30, 2024 04:02PM Vaxcyte, Inc (PCVX) Announces Proposed Share and Warrant Offering
Jan 30, 2024 04:01PM Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Apr 21, 2023 05:25PM Vaxcyte Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 21, 2023 05:25PM Vaxcyte Announces Closing of $575 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Apr 19, 2023 05:40AM Vaxcyte, Inc (PCVX) Prices 11.2M Share and Warrant Offering at $41/sh
Apr 19, 2023 12:26AM Vaxcyte Announces Pricing of $500 Million Public Offering
Apr 19, 2023 12:26AM Vaxcyte Announces Pricing of $500 Million Public Offering
Apr 17, 2023 04:06PM Vaxcyte, Inc (PCVX) Commences Proposed Stock Offering, Size not Disclosed
Apr 17, 2023 04:05PM Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Apr 17, 2023 04:05PM Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Oct 28, 2022 04:01PM Vaxcyte Announces Closing of $690 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 28, 2022 04:01PM Vaxcyte Announces Closing of $690 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
Oct 26, 2022 03:29AM Vaxcyte, Inc (PCVX) Prices $600M Offering at $32/sh
Oct 26, 2022 12:20AM Vaxcyte Announces Pricing of $600 Million Public Offering
Oct 26, 2022 12:20AM Vaxcyte Announces Pricing of $600 Million Public Offering
Oct 24, 2022 04:01PM Vaxcyte (PCVX) Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Oct 24, 2022 04:01PM Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Oct 24, 2022 04:01PM Vaxcyte Announces Commencement of Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jul 13, 2022 06:12AM Vaxcyte's (PCVX) Approach Has Potential to Disrupt PCV Market - Needham & Company Reiterates Buy Rating with $52 Price Target
Apr 5, 2022 08:30AM Vaxcyte to Present at the 21st Annual Needham Virtual Healthcare Conference
Apr 5, 2022 08:30AM Vaxcyte to Present at the 21st Annual Needham Virtual Healthcare Conference
Apr 4, 2022 03:53PM Needham & Company Reiterates Buy Rating on Vaxcyte (PCVX)
Jan 13, 2022 05:37AM Vaxcyte, Inc (PCVX) Prices 2.5M Share IPO at $20/sh
Jan 13, 2022 01:07AM Vaxcyte Announces Pricing of $100 Million Public Offering
Jan 13, 2022 01:07AM Vaxcyte Announces Pricing of $100 Million Public Offering
Jan 12, 2022 04:10PM Vaxcyte, Inc (PCVX) Announces Proposed Stock and Warrant Offering
Jan 12, 2022 04:10PM Vaxcyte Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Jan 12, 2022 04:10PM Vaxcyte Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
Apr 5, 2021 04:30PM Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference
Apr 5, 2021 04:30PM Vaxcyte to Present at 20th Annual Needham Virtual Healthcare Conference
Jul 7, 2020 08:47AM UPDATE: Needham & Company Starts Vaxcyte (PCVX) at Buy
Jun 16, 2020 04:05PM Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jun 16, 2020 04:05PM Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jun 12, 2020 11:17AM Vaxcyte, Inc. (PCVX) IPO opens at $20.80 after pricing at $16
View Older Stories